Terms: = Endocrine gland cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6
13 results:
1. Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition.
Clarke LE; Cook A; Mathavarajah S; Bera A; Salsman J; Habib E; Van Iderstine C; Bydoun M; Lewis SM; Dellaire G
FASEB J; 2021 Nov; 35(11):e22001. PubMed ID: 34674320
[TBL] [Abstract] [Full Text] [Related]
2. Intraoperative Nerve Monitoring in Thyroidectomies for Malignancy: Does It Matter?
Leonard-Murali S; Ivanics T; Nasser H; Tang A; Singer MC
Am Surg; 2022 Jun; 88(6):1187-1194. PubMed ID: 33522279
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic cancer After Neoadjuvant FOLFIRINOX Treatment.
van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
[TBL] [Abstract] [Full Text] [Related]
4. Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience.
Klaassen R; Steins A; Gurney-Champion OJ; Bijlsma MF; van Tienhoven G; Engelbrecht MRW; van Eijck CHJ; Suker M; Wilmink JW; Besselink MG; Busch OR; de Boer OJ; van de Vijver MJ; Hooijer GKJ; Verheij J; Stoker J; Nederveen AJ; van Laarhoven HWM
Mol Oncol; 2020 Sep; 14(9):2176-2189. PubMed ID: 32285559
[TBL] [Abstract] [Full Text] [Related]
5. Perioperative Blood Transfusion and the Prognosis of Pancreatic cancer Surgery: Systematic Review and Meta-analysis.
Mavros MN; Xu L; Maqsood H; Gani F; Ejaz A; Spolverato G; Al-Refaie WB; Frank SM; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4382-91. PubMed ID: 26293837
[TBL] [Abstract] [Full Text] [Related]
6. MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization.
Sacconi B; Argirò R; Diacinti D; Iannarelli A; Bezzi M; Cipriani C; Pisani D; Cipolla V; De Felice C; Minisola S; Catalano C
Eur Radiol; 2016 Mar; 26(3):664-73. PubMed ID: 26024849
[TBL] [Abstract] [Full Text] [Related]
7. Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors.
Miller S; Bhasin N; Urrego H; Moroz K; Rowan BG; Ramayya MS; Makridakis NM
Int J Oncol; 2013 Feb; 42(2):627-34. PubMed ID: 23291911
[TBL] [Abstract] [Full Text] [Related]
8. Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence.
Kitajima K; Ueno Y; Suzuki K; Kita M; Ebina Y; Yamada H; Senda M; Maeda T; Sugimura K
Eur J Radiol; 2012 Nov; 81(11):3557-62. PubMed ID: 22534465
[TBL] [Abstract] [Full Text] [Related]
9. The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.
Knappskog S; Bjørnslett M; Myklebust LM; Huijts PE; Vreeswijk MP; Edvardsen H; Guo Y; Zhang X; Yang M; Ylisaukko-Oja SK; Alhopuro P; Arola J; Tollenaar RA; van Asperen CJ; Seynaeve C; Staalesen V; Chrisanthar R; Løkkevik E; Salvesen HB; Evans DG; Newman WG; Lin D; Aaltonen LA; Børresen-Dale AL; Tell GS; Stoltenberg C; Romundstad P; Hveem K; Lillehaug JR; Vatten L; Devilee P; Dørum A; Lønning PE
Cancer Cell; 2011 Feb; 19(2):273-82. PubMed ID: 21316605
[TBL] [Abstract] [Full Text] [Related]
10. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.
Clayton RN; Raskauskiene D; Reulen RC; Jones PW
J Clin Endocrinol Metab; 2011 Mar; 96(3):632-42. PubMed ID: 21193542
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.
Schick V; Franzius C; Beyna T; Oei ML; Schnekenburger J; Weckesser M; Domschke W; Schober O; Heindel W; Pohle T; Juergens KU
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1775-85. PubMed ID: 18481063
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract] [Full Text] [Related]
13. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
[TBL] [Abstract] [Full Text] [Related]
